206 related articles for article (PubMed ID: 29474933)
1. An optimised multi-arm multi-stage clinical trial design for unknown variance.
Grayling MJ; Wason JMS; Mander AP
Contemp Clin Trials; 2018 Apr; 67():116-120. PubMed ID: 29474933
[TBL] [Abstract][Full Text] [Related]
2. Assessing the impact of efficacy stopping rules on the error rates under the multi-arm multi-stage framework.
Blenkinsop A; Parmar MK; Choodari-Oskooei B
Clin Trials; 2019 Apr; 16(2):132-141. PubMed ID: 30648428
[TBL] [Abstract][Full Text] [Related]
3. Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning.
Schmidt R; Burkhardt B; Faldum A
Methods Inf Med; 2015; 54(5):434-46. PubMed ID: 26429500
[TBL] [Abstract][Full Text] [Related]
4. Multi-arm multi-stage (MAMS) randomised selection designs: impact of treatment selection rules on the operating characteristics.
Choodari-Oskooei B; Blenkinsop A; Handley K; Pinkney T; Parmar MKB
BMC Med Res Methodol; 2024 Jun; 24(1):124. PubMed ID: 38831421
[TBL] [Abstract][Full Text] [Related]
5. Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomes.
Bratton DJ; Parmar MK; Phillips PP; Choodari-Oskooei B
Trials; 2016 Jul; 17(1):309. PubMed ID: 27369182
[TBL] [Abstract][Full Text] [Related]
6. Group sequential multi-arm multi-stage survival trial design with treatment selection.
Wu J; Li Y
J Biopharm Stat; 2024 Jul; 34(4):453-468. PubMed ID: 37455424
[TBL] [Abstract][Full Text] [Related]
7. Controlling the family-wise error rate in multi-arm, multi-stage trials.
Crouch LA; Dodd LE; Proschan MA
Clin Trials; 2017 Jun; 14(3):237-245. PubMed ID: 28545335
[TBL] [Abstract][Full Text] [Related]
8. Group sequential designs for stepped-wedge cluster randomised trials.
Grayling MJ; Wason JM; Mander AP
Clin Trials; 2017 Oct; 14(5):507-517. PubMed ID: 28653550
[TBL] [Abstract][Full Text] [Related]
9. Group sequential t-test for clinical trials with small sample sizes across stages.
Shao J; Feng H
Contemp Clin Trials; 2007 Sep; 28(5):563-71. PubMed ID: 17434814
[TBL] [Abstract][Full Text] [Related]
10. Adaptive extensions of a two-stage group sequential procedure for testing primary and secondary endpoints (II): sample size re-estimation.
Tamhane AC; Wu Y; Mehta CR
Stat Med; 2012 Aug; 31(19):2041-54. PubMed ID: 22733687
[TBL] [Abstract][Full Text] [Related]
11. A web application for the design of multi-arm clinical trials.
Grayling MJ; Wason JM
BMC Cancer; 2020 Jan; 20(1):80. PubMed ID: 32005187
[TBL] [Abstract][Full Text] [Related]
12. Choice of futility boundaries for group sequential designs with two endpoints.
Schüler S; Kieser M; Rauch G
BMC Med Res Methodol; 2017 Aug; 17(1):119. PubMed ID: 28789615
[TBL] [Abstract][Full Text] [Related]
13. Flexible stopping boundaries when changing primary endpoints after unblinded interim analyses.
Chen LM; Ibrahim JG; Chu H
J Biopharm Stat; 2014; 24(4):817-33. PubMed ID: 24697500
[TBL] [Abstract][Full Text] [Related]
14. Two-stage optimal designs based on exact variance for a single-arm trial with survival endpoints.
Shan G
J Biopharm Stat; 2020 Sep; 30(5):797-805. PubMed ID: 32129130
[TBL] [Abstract][Full Text] [Related]
15. Designing multi-arm multi-stage clinical trials using a risk-benefit criterion for treatment selection.
Jaki T; Hampson LV
Stat Med; 2016 Feb; 35(4):522-33. PubMed ID: 26456537
[TBL] [Abstract][Full Text] [Related]
16. Adding new experimental arms to randomised clinical trials: Impact on error rates.
Choodari-Oskooei B; Bratton DJ; Gannon MR; Meade AM; Sydes MR; Parmar MK
Clin Trials; 2020 Jun; 17(3):273-284. PubMed ID: 32063029
[TBL] [Abstract][Full Text] [Related]
17. Designs for clinical trials with time-to-event outcomes based on stopping guidelines for lack of benefit.
Royston P; Barthel FM; Parmar MK; Choodari-Oskooei B; Isham V
Trials; 2011 Mar; 12():81. PubMed ID: 21418571
[TBL] [Abstract][Full Text] [Related]
18. Multi-arm trials with multiple primary endpoints and missing values.
Hasler M; Hothorn LA
Stat Med; 2018 Feb; 37(5):710-721. PubMed ID: 29108137
[TBL] [Abstract][Full Text] [Related]
19. Some recommendations for multi-arm multi-stage trials.
Wason J; Magirr D; Law M; Jaki T
Stat Methods Med Res; 2016 Apr; 25(2):716-27. PubMed ID: 23242385
[TBL] [Abstract][Full Text] [Related]
20. Optimal design of multi-arm multi-stage trials.
Wason JM; Jaki T
Stat Med; 2012 Dec; 31(30):4269-79. PubMed ID: 22826199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]